Department of Psychiatry, School of Medicine and Dentistry, University of Rochester, 300 Crittenden Boulevard, Rochester, New York 14620, USA.
J Stud Alcohol Drugs. 2010 Jan;71(1):71-7. doi: 10.15288/jsad.2010.71.71.
This study examined the associations of pretreatment and posttreatment depressive symptoms with drinking outcomes in the year following treatment in Project MATCH (Matching Alcoholism Treatments to Client Heterogeneity), a multisite clinical trial of behavioral treatments for alcohol-use disorders.
Data from 1,726 participants were modeled using generalized estimating equations to examine drinking frequency and intensity, as reflected by percentage days abstinent (PDA) and average drinks per drinking day (DDD). We predicted that patients who reported more pretreatment and posttreatment depressive symptoms would report greater drinking frequency (PDA) and more intense drinking (DDD) across the 12-month follow-up period.
Pretreatment Beck Depression Inventory (BDI) scores predicted more frequent and intense drinking in the year following treatment, although not after accounting for posttreatment BDI scores, which were associated with the drinking outcomes as hypothesized. Patients who reported more depressive symptoms in the year following treatment reported less abstinence (PDA) and more intense drinking (DDD) than patients with fewer posttreatment depressive symptoms.
Our findings underscore the importance of obtaining repeated assessments of depression during the course of substance use treatment. Moreover, the data suggest the potential utility of augmenting standard chemical dependency care with depression-focused interventions for alcohol-dependent patients whose depressive symptoms do not subside during treatment.
本研究考察了治疗前和治疗后抑郁症状与治疗后 1 年内饮酒结果之间的关系,这是一项针对酒精使用障碍的行为治疗的多中心临床试验(MATCH 项目,即匹配酒精治疗以适应患者异质性)。
使用广义估计方程对 1726 名参与者的数据进行建模,以检查饮酒频率和强度,反映为戒酒天数百分比(PDA)和平均每日饮酒量(DDD)。我们预测,报告更多治疗前和治疗后抑郁症状的患者在 12 个月的随访期间报告更多的饮酒频率(PDA)和更强烈的饮酒(DDD)。
治疗前贝克抑郁量表(BDI)评分预测了治疗后 1 年内更频繁和更强烈的饮酒,尽管在考虑到治疗后 BDI 评分后并不如此,后者与假设的饮酒结果相关。与治疗后抑郁症状较少的患者相比,报告治疗后 1 年内抑郁症状更多的患者报告更少的戒酒(PDA)和更强烈的饮酒(DDD)。
我们的发现强调了在物质使用治疗过程中反复评估抑郁的重要性。此外,这些数据表明,对于那些在治疗期间抑郁症状没有减轻的酒精依赖患者,在标准的化学依赖护理中增加针对抑郁的干预措施可能具有潜在的益处。